Physician profile
Ami E Rowe
NPI 1336315092
$3,032.69
in general payments reported to CMS, 2019-2025
50 companies · $39.50 in 2025
The $39.50 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,491 · 2022: $1,307 · 2023: $195 · 2025: $39.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $291.69 | 2021-2022 | |
| Asd Specialty Healthcare, LLC | $243.17 | 2022-2023 | |
| Amgen INC. | $208.87 | 2021-2022 | |
| Pfizer INC. | $195.71 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $162.28 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $143.55 | 2021-2022 | |
| Incyte Corporation | $110.37 | 2021-2022 | |
| Glaxosmithkline, LLC. | $106.76 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $93.90 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.80 | 2021-2022 | |
| Myovant Sciences INC. | $87.58 | 2021-2022 | |
| Astellas Pharma US INC | $84.28 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $81.91 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $81.83 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $65.00 | 2021-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.